298 related articles for article (PubMed ID: 3511705)
1. Fibrocystic breast disease: pathophysiology, pathomorphology, clinical picture, and management.
Vorherr H
Am J Obstet Gynecol; 1986 Jan; 154(1):161-79. PubMed ID: 3511705
[TBL] [Abstract][Full Text] [Related]
2. Fibrocystic disease of the breast.
Greenblatt RB; Samaras C; Vasquez JM; Nezhat C
Clin Obstet Gynecol; 1982 Jun; 25(2):365-71. PubMed ID: 7105513
[TBL] [Abstract][Full Text] [Related]
3. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk.
Spicer DV; Ursin G; Parisky YR; Pearce JG; Shoupe D; Pike A; Pike MC
J Natl Cancer Inst; 1994 Mar; 86(6):431-6. PubMed ID: 8120917
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptives, postmenopausal oestrogen-progestagen use and breast cancer.
Gambrell RD
J Obstet Gynaecol (Lahore); 1984 Apr; 4(Suppl 2):S121-7. PubMed ID: 12339859
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and endocrinology of benign breast disease.
Wang DY; Fentiman IS
Breast Cancer Res Treat; 1985; 6(1):5-36. PubMed ID: 3902125
[TBL] [Abstract][Full Text] [Related]
6. Exogenous progestins and breast cancer.
Stanford JL; Thomas DB
Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
[TBL] [Abstract][Full Text] [Related]
7. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
8. Exogenous hormone use and fibrocystic breast disease by histopathologic component.
Berkowitz GS; Kelsey JL; LiVolsi VA; Merino MJ; Holford TR; Hildreth NG; Ort S; O'Connor TZ; White C
Int J Cancer; 1984 Oct; 34(4):443-9. PubMed ID: 6490201
[TBL] [Abstract][Full Text] [Related]
9. Sex steroids and breast cancer prevention.
Spicer DV; Pike MC
J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
[TBL] [Abstract][Full Text] [Related]
10. Biology of female sex hormone action in relation to contraceptive agents and neoplasia.
King RJ
Contraception; 1991 Jun; 43(6):527-42. PubMed ID: 1651204
[TBL] [Abstract][Full Text] [Related]
11. Progestins and breast cancer: an epidemiologic review.
Staffa JA; Newschaffer CJ; Jones JK; Miller V
Fertil Steril; 1992 Mar; 57(3):473-91. PubMed ID: 1740192
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
[TBL] [Abstract][Full Text] [Related]
13. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
14. Benign breast tumor and estrogenic hormones: a population-based retrospective study.
Nomura A; Comstock GW
Am J Epidemiol; 1976 May; 103(5):439-44. PubMed ID: 179318
[TBL] [Abstract][Full Text] [Related]
15. The metabolic impact of oral contraceptives.
Krauss RM; Burkman RT
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443
[TBL] [Abstract][Full Text] [Related]
16. Drugs that affect the breast and lactation.
Dickey RP; Stone SC
Clin Obstet Gynecol; 1975 Jun; 18(2):95-111. PubMed ID: 1095275
[TBL] [Abstract][Full Text] [Related]
17. Effects on the breast of drugs used in fertility regulation.
Mauvais-Jarvis P
Hum Reprod; 1987 Feb; 2(2):159-62. PubMed ID: 3473070
[TBL] [Abstract][Full Text] [Related]
18. Fibrocystic change and fibrocystic disease of the breast.
Drukker BH; deMendonca WC
Obstet Gynecol Clin North Am; 1987 Sep; 14(3):685-702. PubMed ID: 3323971
[TBL] [Abstract][Full Text] [Related]
19. Oral contraceptive use and fibrocystic breast disease among pre- and postmenopausal women.
Berkowitz GS; Kelsey JL; LiVolsi VA; Holford TR; Merino MJ; Ort S; O'Connor TZ; Goldenberg IS; White C
Am J Epidemiol; 1984 Jul; 120(1):87-96. PubMed ID: 6741927
[TBL] [Abstract][Full Text] [Related]
20. Hormones and risk of breast cancer.
Onnis A; Marchetti M; Graziottin A
Eur J Gynaecol Oncol; 1983; 4(1):13-7. PubMed ID: 6305660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
